Physician

Madhavi Rayapudi, MD

According to 2025 Medicare claims, Madhavi Rayapudi, MD (NPI: 1215971668) practices infectious disease in the Atlanta-Sandy Springs-Roswell, GA market, with the plurality of this provider's patient population coming from Forsyth, GA. This provider's primary affiliated billing organization is INFECTIOUS DISEASE PROFESSIONALS, LLC (NPI: 1174613459; TIN: 90-0140405) and primary practice location at 30040-2727.

Rayapudi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 516 traditional Medicare patients, billed 2,089,355 HCPCS/CPT codes, and received $1,563,473 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 856 prescription claims across 213 beneficiaries totaling $492,573 in drug costs, led by Hizentra (Immun Glob G(Igg)/Pro/Iga 0-50). DME data shows 36 claims. Open Payments data shows 57 records totaling $1,238. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $409,567 and ending at $492,573. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $9,741 and ending at $3,876.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	621	998,706	$1,345,391
2016	597	828,301	$1,327,996
2017	603	1,244,058	$1,411,346
2018	612	1,101,870	$1,220,571
2019	657	1,309,102	$1,522,788
2020	539	823,773	$1,100,766
2021	520	1,315,541	$1,203,667
2022	562	1,783,032	$1,471,889
2023	537	2,525,018	$1,643,963
2024	516	2,089,355	$1,563,473

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	275	1,586	$409,567
2016	252	1,271	$573,325
2017	270	1,201	$366,234
2018	212	964	$620,464
2019	234	980	$404,741
2020	235	982	$491,082
2021	196	922	$655,505
2022	182	747	$667,512
2023	196	781	$563,431
2024	213	856	$492,573

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	18	$9,398
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	13	$23,207
2021	N/R	136	$55,305
2022	N/R	62	$110,949
2023	N/R	12	$8,590
2024	N/R	36	$34,335

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	216	272	$129
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	341	2,029	$98
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	288	3,066	$61
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	204	5,054	$49
J7050	Infusion, normal saline solution, 250 cc	196	9,436	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hizentra	Immun Glob G(Igg)/Pro/Iga 0-50	13	364	$114,290
Gammagard Liquid	Immun Glob G(Igg)/Gly/Iga Ov50	14	392	$92,613
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	13	390	$55,164
Daptomycin	Daptomycin	111	767	$44,211
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	12	336	$41,054

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	N	N/R	12	$20,858
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	12	$9,521
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	12	$3,956

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	57	$1,238	ViiV Healthcare Company
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Madhavi Rayapudi, MD?

Tedicare shows public-source Medicare data for Madhavi Rayapudi, MD (NPI 1215971668), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Madhavi Rayapudi, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Madhavi Rayapudi, MD?

Madhavi Rayapudi, MD is linked to INFECTIOUS DISEASE PROFESSIONALS, LLC (billing NPI 1174613459) in the available physician profile data.

Does Madhavi Rayapudi, MD have Open Payments data?

Madhavi Rayapudi, MD has 57 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.